Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Non Operating Interest Expenses (2023 - 2025)

Basel Medical (BMGL) posted Non Operating Interest Expenses of -$215784.0 for Q4 2025, down 121.05% sequentially from -$97619.0 in Q4 2024, and down 121.05% YoY from $1.0 million in Q4 2024.

Analysis

Basel Medical (BMGL) Non Operating Interest Expenses (2023 - 2025) Analysis & Trends

Basel Medical has reported Non Operating Interest Expenses for 2 years, with the latest figure at -$215784.0 in Q4 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 HCA Healthcare 89.64 Bn 88.63 Bn 15.19 Bn 599.00 Mn
2 Tenet Healthcare 22.12 Bn 19.95 Bn 4.45 Bn 204.00 Mn
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn 32.80 Mn
4 Davita 11.85 Bn 11.16 Bn 1.16 Bn 150.26 Mn
5 Universal Health Services 10.14 Bn 10.00 Bn 3.29 Bn 39.91 Mn
6 Ensign 9.93 Bn 9.61 Bn 306.24 Mn 1.93 Mn
7 Chemed 6.89 Bn 6.85 Bn 221.47 Mn 21.79 Mn
8 Pacs 6.75 Bn 6.58 Bn 338.46 Mn 6.04 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn -
10 Basel Medical 7.33 Mn 6.54 Mn - -215,784.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -215,784.00
Jun 30, 2025 848,452.00
Dec 31, 2024 -97,619.00
Dec 31, 2023 -96,123.00